Skip to the page

Data / Form D filings / Oncologic, Inc. / DE

Oncologic, Inc. / DE: Form D filing

Oncologic, Inc. / DE, a company in Orlando, FL, filed a Form D with the SEC in 2026. The latest, on August 5, 2026, reports $26.7 million sold of a $26.7 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
7300 Sand Lake Commons Boulevard Suite 327, Orlando, FL, 32819
Phone
(407) 476-4126
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2148177

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 5, 2026New notice$26,749,995$26,749,9953Jul 20, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Chakravarthy ToletiExecutive Officer, Director
Sireesha ToletiDirector
Willem BritzExecutive Officer
Clynt TaylorExecutive Officer

Other companies in Florida that filed recently

Every Form D from the week of Aug 3, 2026 · All recent filings in Florida · All recent Other filings

Read from SEC EDGAR. Amount sold is what Oncologic, Inc. / DE reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.